ISI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ionis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 64.34 EUR 0.5% Market Closed

Market Cap: €9.2B

I	Ionis Pharmaceuticals Inc SWB:ISI	US
	Tyler Technologies Inc NYSE:TYL	US
C	Chilled & Frozen Logistics Holdings Co Ltd TSE:9099	JP

Profitability Summary

Ionis Pharmaceuticals Inc's profitability score is 22/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Gross Margin is Increasing

98% > 98%

Negative Operating Margin

-33%

Negative 3Y Average Operating Margin

-51%

Operating Margin is Increasing

-81% > -33%

Negative Net Margin

-31%

Negative 3Y Average Net Margin

-46%

Net Margin is Increasing

-57% > -31%

Negative Free Cash Flow Margin

-92%

Negative 3Y Average Free Cash Flow Margin

-57%

Declining Free Cash Flow Margin

-69% > -92%

Negative ROE

-68%

Negative 3Y Average ROE

Positive 3Y Average ROIC

20%

Declining ROIC

-102% > -258%

View All

Hide

Collapse

22 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.